James is the CEO of Glass Pharms, the UK's first and largest cultivator of medical cannabis for CBPMs. Trained as a chemist, he has spent his career across technology sectors internationally — leading both large corporates and founding startups. His objective, analytical approach and deep industry expertise make him an exceptional judge.

Pierre joined Grow Group in 2019 after a 30+ year career in pharmaceutical industry across the Netherlands, Germany, France and the UK. He is driven by improving patient access to medical cannabis and serves as chairman of the Dutch MS patient association.

A qualified lawyer with 15+ years as MD of a pharmaceutical company, Sita founded COMM-OP Europe and co-founded EUMCA — the European Medical Cannabis Association — in 2019. An international advocate at government hearings since 2016, uniting industry, patients, medical associations and science with one voice.

Director of International Sales for Boveda, Vivi and CVault, overseeing global expansion across 120+ countries, educating markets on post-harvest cannabis storage. Kate also co-founded the "I Know a Girl" initiative and co-hosts Elevate 8 events globally to empower female professionals.

A global strategist in pharmaceutical cannabis and the driving force behind SOMAÍ Pharmaceuticals. Recognised as an international authority on large-scale cannabis infrastructure, he has advised 59+ companies and helped build 27 facilities across the US and Europe.

CEO of Buffalo Extraction Systems, a leading turnkey solutions provider of state-of-the-art cannabis extraction systems. With extensive experience across Africa, North America and Asia Pacific, a proven business leader delivering successful cross-functional projects in the extraction space.

Founder and CEO of Paralab with 30+ years of pharmaceutical expertise. Recognised for bridging science, regulation and industrial innovation, enabling producers worldwide to meet EU-GMP standards across Europe, Israel and Latin America.

4th-generation greenhouse grower from a family nursery established in 1890. Franz brings unparalleled cultivation knowledge to the medical cannabis sector, having transitioned from Clone production to advising large-scale medical cannabis producers.

Co-founder and Chief Revenue Officer of 4C Labs, and Director at Emerald Health. A senior leader bridging cultivation technology and commercial strategy, James brings founder-level insight and commercial depth to evaluating innovation in AgriTech and cannabis technology.

24+ years in global medical cannabis, specialising in cultivation, post-harvest operations and international trade. VP of Global Cannabis Exchange and President of Avitas Global, with expertise spanning licensing, supply chain and operational execution at scale across Europe, North America and Asia.

Co-founder of cannabiz.com.au, Australia and New Zealand's leading legal cannabis media platform. Previously co-founder and CEO of Mumbrella — Asia-Pacific's leading B2B media brand — which he grew to $10m revenue. Martin began his career as a journalist in London.

Born and raised in a Dutch greenhouse, holds a master's degree in plant science from Wageningen University. Has consulted internationally on cannabis cultivation with involvement in trials at Wageningen. His understanding of pharmaceutical, horticultural and hobby industry collaboration is central to his work.

CEO and co-founder of Ziel, pioneer in the application of radio frequency technology to reduce microbial pathogens across cannabis and agricultural products. Former executive in pharmaceutical, energy and financial industries. Ziel is the leading choice of cannabis operators across North America and Europe.

Principal at Leafy Tunnel, investing in medical cannabis, medical psychedelics and health tech startups. Began career at EY in Washington DC before corporate finance at Holistic Industries. Holds degrees from University of Maryland (cum laude), MBA from London Business School, and is a Certified Public Accountant.

President of the German Cannabis Industry Association (BvCW) and VP Government Relations at Aurora Europe. A key figure in Germany's cannabis liberalisation with 15 years of government relations experience gained at Canopy Growth and BlackBerry across Europe, Africa and the Middle East.

Experienced investment professional with a background in private equity and growth capital. Former Managing Director at MPC Capital, with deep expertise in healthcare, pharmaceutical platforms, infrastructure and real assets. His financial acumen brings rigorous evaluation to innovation and scalability in cannabis.

Global Strategic Consultant specialising in cannabis, plant-based wellness, governance and international market expansion across the UK, Europe and emerging markets. Co-Founder and Chairwoman of EmpowHer Cannabis Society — a global network spanning 40+ countries.